Medtech

Coloplast closes book on lengthy lawsuit: "It has cost way, way too much money"

As CEO of Coloplast, Kristian Villumsen has learned a lot from the expensive lawsuits in the US regarding transvaginal mesh, and the medical device company has emerged strengthened from the ordeal.
After the transvaginal mesh case, Coloplast CEO Kristian Villumsen will focus on selling Class 3 products in the US surgical business to avoid future litigation similar to the billion-dollar abdominal mesh case. | Photo: Stine Bidstrup
After the transvaginal mesh case, Coloplast CEO Kristian Villumsen will focus on selling Class 3 products in the US surgical business to avoid future litigation similar to the billion-dollar abdominal mesh case. | Photo: Stine Bidstrup
by ULRICH QUISTGAARD

Coloplast’s headquarters in Humlebæk, Denmark, is filled with mixed emotions after the medical device company has settled a 12-year-long case in US courts over the company’s transvaginal mesh that became entangled in women’s abdomens.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
    • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Related articles

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading

    Jobs